Charged Alpha Stock Encyclopedia

Colton Thomas
  • 0.0 (0)
  • Investing

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close: what they do, how the numbers look, what Wall Street thinks, the bull case, the bear case. 🛠️ Check out our free beginner-friendly screening tools for stocks, ETFs, options, crypto, bonds, REITs & more at https://chargedalpha.com — no signup, no paywall. 📊 What you get in every episode: Company overview & competitive moat Full financial breakdown — valuation, revenue, margins, cash flow Analyst consensus & price targets Bull case vs. bear case Peer comparison, options flow & insider activity Key metrics to watch ⚠️ Not financial advice. For educational purposes only. Episodes are researched, written, and produced using AI-assisted tools. All data aggregated from publicly available sources. #stocks #investing #S&P500 #stockanalysis #chargedalpha #financialdata #earningsreport #earnings

  1. 1d ago

    UMC (UMC): Net Income Up 161% - But Two-Thirds Wasn’t From Chips

    United Microelectronics Corporation (UMC) Q2 2026 — United Microelectronics (UMC), Taiwan's mature-node specialty foundry, reported Q2 2026 revenue of NT$68.73B (US$2.18B, +12.6% QoQ, +17.0% YoY) at the top end of guidance, gross margin up to 32.5% from 29.2%, operating income up 32.6% to NT$14.95B on utilization of 85% and wafer shipments up 10.6%. Net income attributable of NT$42.26B was up 161% QoQ - EPS NT$3.39, or US$0.537 per ADS against a consensus of about US$0.158. But NT$30.24B of that pre-tax profit was NET NON-OPERATING INCOME, up 463% QoQ and 67% of pre-tax profit, and the earnings deck never says what it was. Core operating EPS taxed at a normal 17% is about US$0.157 per ADS - almost exactly the consensus. The entire beat was the line the company did not explain. Management also raised 2026 capex from $1.5B to $2.0B, approved roughly $5B of phased expansion across 2026-27 (Singapore P4 cleanroom plus a new Tainan fab shell), and guided depreciation to grow low-teens percent for at least two years. Our call: AVOID, 3/5, fair value $11.50 per ADS versus $17.11 - and no cell in our mid-cycle grid reaches today's price. UMC just reported net income up 161% in a single quarter and beat the analyst estimate by thirty-eight cents a share - and the stock did essentially nothing. That was not a market failure. Q2 2026 revenue was NT$68.73 billion (about US$2.18 billion), up 12.6% sequentially and 17% year over year, at the top end of guidance. Gross margin expanded from 29.2% to 32.5%. Operating income rose 32.6% to NT$14.95 billion. All of that is real. But net income attributable was NT$42.26 billion, and pre-tax profit was NT$45.19 billion - which means NT$30.24 billion, sixty-seven percent of pre-tax profit, was NET NON-OPERATING INCOME, up 463% from NT$5.4 billion in Q1. The earnings materials do not tell you what it was. Tax the operating line at a normal 17% and core earnings come to about 15.7 US cents per ADS. The consensus estimate was 15.8 cents. On the business of making chips, UMC delivered exactly what was expected. Meanwhile management raised 2026 capex from $1.5 billion to $2.0 billion, approved roughly $5 billion of phased expansion, and guided depreciation to grow low-teens percent for at least two years - into a quarter already running 85% utilization. Our mid-cycle model says $11.50 per ADS against $17.11 today. THE CALL: AVOID (3/5, A REAL OPERATING QUARTER WRAPPED IN A HEADLINE THAT IS NOT REPEATABLE) — base-case value ~$11.50 vs ~$17.11 today. What to watch: Silicon photonics revenue disclosed as its own line and large enough to matter once the 12-inch platform opens to general customers in 2027, plus the Intel 12nm collaboration hitting its milestones on schedule - PDK complete late 2026, tape-outs in 2027, meaningful production 2028. Either would convert optionality into an actual earnings estimate and we would raise the multiple, not just the numbers. The near-term risk to respect is the non-operating line: whatever produced NT$30.24 billion this quarter almost certainly does not recur, so Q3 net income can fall sharply while the foundry itself gets better - utilization above 90% and gross margin in the mid-30s alongside a net income number that looks like a collapse. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  2. 6d ago

    NextEra Energy Stock: It Beat Earnings and Is Buying Dominion — So Why We Say HOLD (NEE Q2 2026)

    NextEra Energy (NEE) Q2 2026 — NextEra Energy (NEE), the largest U.S. electric utility and the world's biggest generator of wind and solar, reported a solid Q2 2026 on July 24: adjusted EPS of $1.15 beat the ~$1.10 estimate (+9.5% YoY), though revenue of $7.53B missed the ~$8.0B consensus. Florida Power & Light earned $1.41B ($0.67/sh) as its regulated rate base grew 9.3%; NextEra Energy Resources earned $1.29B adjusted ($0.62/sh) and signed another 3.6 GW of renewables/storage (incl. 2 GW batteries), lifting its backlog to ~35 GW. Management reaffirmed FY2026 adjusted EPS of $3.92-$4.02 (targeting the top end) and >8%/yr long-range EPS growth through 2032 — but slowed dividend growth to ~6% (from ~10%) to help fund the pending, transformational Dominion Energy merger. The stock (~$89, roughly flat on the print) trades at ~22x forward earnings, a premium to peers. Our blended P/E + dividend-discount fair value lands near $90 — essentially the price. Our call: HOLD, 3/5 — a notch below the Street's ~$99 Buy. NextEra Energy is the bluest of blue-chip utilities — the largest electric utility in America and the world's number-one generator of wind and solar, built on two engines: Florida Power & Light, the gold-standard regulated utility serving ~12M Floridians, and NextEra Energy Resources, the world's leading clean-power developer. Q2 2026 (reported July 24) was a solid quarter: adjusted EPS of $1.15 beat the ~$1.10 estimate (+9.5% YoY) and GAAP EPS was $1.50, though revenue of $7.53B came in light versus the ~$8.0B consensus. FPL earned $1.41B ($0.67/sh) on 9.3% rate-base growth; Resources earned $1.29B adjusted ($0.62/sh) and added 3.6 GW to its renewables/storage backlog (incl. 2 GW of batteries), pushing the pipeline to ~35 GW. Management reaffirmed FY2026 adjusted EPS guidance of $3.92-$4.02 — and said it expects the top end — plus a long-range plan of >8%/yr adjusted-EPS growth through 2032. The catch: it's underwriting the biggest merger in utility history, the pending acquisition of Dominion Energy (announced May 2026, ~12-18 months to close), which also slows dividend growth from ~10% to ~6% a year. At ~$89 the stock trades near 22x forward earnings — a clear premium to the 17-18x utility average — with net debt near 6x EBITDA and a ~2.8% yield. Because a capex-heavy regulated + clean-energy utility runs free cash flow negative by design, we value NEE on a utility frame: a fair P/E (20-22x on 2026-27 EPS) plus a two-stage dividend-discount model. Both cluster near $90 — essentially today's price, i.e., no margin of safety. Our call: HOLD, 3/5. A best-in-class utility, fully priced, taking on enormous change — and we're a notch more cautious than the Street's Buy (~$99 avg, 24 of 36 analysts). We'd add on real weakness in the mid-$80s and watch the Dominion regulatory calendar closely. Do your own research; this is not financial advice. THE CALL: HOLD (3/5, A BEST-IN-CLASS UTILITY, FULLY PRICED — A BEAT WITH NO MARGIN OF SAFETY, NOW UNDERWRITING A MEGA-MERGER) — base-case value ~$90 vs ~$89 today. What to watch: clean progress on the Dominion merger — key state and federal regulatory approvals landing without painful concessions — which would lift the single biggest overhang and could prompt an upgrade; the risks to respect are the merger bogging down in the states or the balance sheet straining and pressuring the dividend, and at ~22x forward earnings with no margin of safety even a modest stumble could re-rate the premium multiple lower Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  3. Jul 24

    Gentherm Stock: It CRUSHED Earnings and Popped 26% — So Why We Say HOLD (THRM Q2 2026)

    Gentherm (THRM) Q2 2026 — Gentherm (THRM), the world leader in automotive climate-controlled seats, reported a record Q2 2026: revenue rose 11% to a record $416.2M (+9.5% ex-FX), and ADJUSTED diluted EPS of $0.75 crushed the ~$0.56 estimate (+39% YoY). New automotive business awards hit $690M, management RAISED full-year guidance (revenue $1.55–1.65B, adj EBITDA $185–200M, adj FCF $85–100M), and the board authorized a new $400M buyback. The stock popped ~26% to ~$46, a fresh 52-week high. But under the beat: the $0.75 is ADJUSTED — GAAP EPS was $0.14, GAAP operating income FELL 55% to $10.7M, adjusted EBITDA margin compressed to 11.7% (−50 bps), and GAAP free cash flow was NEGATIVE (−$1.2M) as ~$13M of Modine merger costs and rising warranty accruals bit. Our owner-earnings DCF lands fair value near $42 — below the ~$46 price and below every Street target ($34–$44, avg ~$39). Our call: HOLD, 3/5. Gentherm (NASDAQ: THRM) is the quiet, under-covered world leader in automotive thermal comfort — climate-controlled seats, heated steering wheels, and the fast-growing lumbar-and-massage systems inside a huge share of the world's cars. Q2 2026 looked like a blowout: record revenue of $416.2M (+11%, +9.5% ex-FX), ADJUSTED diluted EPS of $0.75 vs the ~$0.56 estimate (+39% YoY), $690M of new automotive business awards, a raised full-year guide (revenue $1.55–1.65B, adj EBITDA $185–200M, adj FCF $85–100M), and a new $400M buyback. The stock gapped ~26% in a single day to ~$46, a fresh 52-week high. The engine of the growth is real and defensible: content-per-vehicle. Gentherm's core automotive climate revenue grew ~14 points FASTER than light-vehicle production, led by lumbar & massage (+38%) and China. So the debate isn't the top line — it's the fine print. That $0.75 is adjusted: it adds back ~$13M of Modine merger costs, ~$6M of restructuring, and an FX swing. GAAP EPS was just $0.14, GAAP operating income FELL 55% to $10.7M, adjusted EBITDA margin actually COMPRESSED to 11.7% (−50 bps) on higher material costs and rising warranty accruals, and GAAP free cash flow was NEGATIVE (−$1.2M in Q2). The balance sheet is a fortress (net leverage ~0.3x, liquidity $502M), and the pending combination with Modine's Performance Technologies (~$2.6B pro-forma revenue) is genuine optionality — but it's not in guidance or fully in the price, and it carries integration risk. Our owner-earnings DCF, giving full credit to the content story, lands fair value near $42 — below the ~$46 the stock popped to, and below every published Street target ($34–$44, avg ~$39). A good business, but no margin of safety after a 26% one-day move. Our call: HOLD, 3/5. Own it for the content-growth story and Modine optionality, add on a pullback toward the high $30s, and don't confuse a great quarter with a great entry. Not financial advice. THE CALL: HOLD (3/5, A REAL BEAT, A RICHER PRICE — A CONTENT-GROWTH STORY WITH NO MARGIN OF SAFETY AFTER A 26% POP) — base-case value ~$42 vs ~$46 today. What to watch: the Modine Performance Technologies combination (expected to close early Q4 2026, ~$2.6B pro-forma revenue / ~$322M pro-forma EBITDA) closing cleanly with visible synergies, adjusted-EBITDA margin recovering back above 12%, and the company actually deploying its new $400M buyback — that transformation, executed, would justify a higher value; the risk to respect is a downturn in light-vehicle production hitting already-thin margins, or Modine integration stumbling, with rising warranty accruals and negative GAAP free cash flow the early tells to watch every quarter Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  4. Jul 22

    GE Vernova Stock: Orders Just Exploded +88% and It RAISED Guidance — So Why We Say HOLD

    GE Vernova (GEV) Q2 2026 — GE Vernova (GEV), the power-and-grid company spun out of the old General Electric, reported a blockbuster Q2 2026: orders exploded +88% organically to $24.2B, revenue rose 22% to $11.1B (+12% organic), adjusted EBITDA jumped to $1.25B (an 11.3% margin, +340bps organic), and free cash flow hit $5.1B — more than all of 2025. Management RAISED full-year guidance, nearly DOUBLING the free-cash-flow outlook to $11.5–12.5B and lifting revenue to $45.5–46.5B, on a $176B backlog. GAAP EPS was $2.47 (+33% YoY), a touch light versus the Street's number. The stock (~$1,079, flat on the print) has roughly doubled off its $530 low and sits ~10% below its $1,196 high. The catch: at ~48x adjusted EBITDA, even our optimistic supercycle DCF lands fair value near $800 — below the price — because much of that free cash flow is customer advance payments that normalize. Our call: HOLD, 3/5. GE Vernova is the market's purest play on the electricity supercycle — the energy business carved out of the old General Electric in 2024, selling exactly what AI data centers, reshoring, and electrification suddenly can't get enough of: gas turbines and grid equipment. Q2 2026 was a blowout on the metrics that matter: orders exploded +88% organically to $24.2B, revenue rose 22% to $11.1B (+12% organic), adjusted EBITDA jumped to $1.25B (an 11.3% margin, up 340bps organically), and free cash flow surged to $5.1B — more than all of 2025. Power orders rose +134% (gas equipment under contract went from 100 to 116 GW, targeting 125+ by year-end); Electrification revenue grew +68% with a ~1.7 book-to-bill; only Wind lagged (revenue −10%, losses widening). Management RAISED guidance again — nearly DOUBLING the FCF outlook to $11.5–12.5B and lifting revenue to $45.5–46.5B — on a $176B backlog. GAAP EPS was $2.47 (+33% YoY), a touch light vs the Street. So the debate isn't quality — it's price. The stock has roughly doubled off its $530 low to ~$1,079, ~48x adjusted EBITDA. Here's the honest nuance: a big slice of that gorgeous free cash flow is customer down-payments on the booming gas backlog — advance payments that flatter cash today and normalize as turbines ship. Strip them out and anchor on normalized owner earnings (~$4.5B), and even our optimistic supercycle DCF lands fair value near $800 — below today's price; even the supercycle path at a 9% discount rate is only ~$1,025, still under the stock. A wonderful business with no margin of safety. Our call: HOLD, 3/5. We're not sellers of a compounder this good, but at these levels we wouldn't chase it — and we're more cautious than the Street's bullish ~$1,160 target (Buy, 21 of 28 analysts, 0 sells). Own it for the quality, add on real weakness toward $800, and watch margins and cash conversion. Not financial advice. THE CALL: HOLD (3/5, A SUPERCYCLE WINNER, PRICED BEYOND PERFECTION — A BEAT-AND-RAISE WITH NO MARGIN OF SAFETY) — base-case value ~$800 vs ~$1079 today. What to watch: durable margin expansion plus free cash flow that holds up as gas-turbine advance payments normalize — and Wind finally turning profitable — which would prove the cash generation is structural, not just working-capital timing, and justify the premium multiple, prompting an upgrade; the risk to respect is a stall in orders, a crack in the AI-data-center power narrative, or a margin disappointment, which at ~48x adjusted EBITDA could re-rate the stock hard Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  5. Jul 21

    Novartis Stock (NVS): It Beat Q2 AND Returned to Growth — So Why We Say HOLD

    Novartis AG (NVS) Q2 2026 — Novartis (NVS), the ~$285B Swiss pharma giant, reported Q2 2026 before the open on July 21: net sales of $14.4B rose +1% in constant currency (+3% USD) — a RETURN TO GROWTH after Q1's -5% cc decline — and core operating income of $5.94B beat the ~$5.3B consensus at a 41.2% margin. Core EPS of $2.41 beat the $2.17 estimate. But reported (IFRS) EPS fell -17% to $1.71, net income dropped -19% on higher taxes and interest, and free cash flow slipped -12% to $5.6B as net debt DOUBLED to $39.4B on M&A (Avidity, Myricx). Entresto fell -50% to $1.18B as US generics launched, while Kisqali (+43%), Kesimpta (+32%), Scemblix (+89%), Pluvicto (+43%) and Leqvio (+59%) more than filled the hole. FY2026 guidance reaffirmed (net sales grow LSD, core op income decline LSD). The ADR fell ~2.7% to ~$149.56 on the print. Novartis (NVS) is one of the two or three largest drugmakers on earth — a ~$285B Swiss pure-play innovative-medicines company (Aa3/AA-) led by Vas Narasimhan. Q2 2026 was, on the surface, a strong quarter: net sales of $14.4B returned to growth (+1% cc, +3% USD), core operating income of $5.94B beat the ~$5.3B Street estimate at a superb 41.2% margin, core EPS of $2.41 beat $2.17 — and the crown-jewel drug Kisqali won a surprise 6-month FDA pediatric exclusivity. The growth engine (Kisqali +43%, Kesimpta +32%, Scemblix +89%, Pluvicto +43%, Leqvio +59%, Fabhalta +88%) more than absorbed the Entresto patent cliff (-50% to $1.18B on US generics; EU LOE in November). Yet the ADR FELL ~3% on the print. Why? Underneath the polished 'core' numbers, reported IFRS EPS fell -17% to $1.71, net income dropped -19%, and free cash flow slipped -12% — because net debt DOUBLED from $21.9B to $39.4B in six months funding a $15.3B M&A spree. Management reaffirmed a trough-year guide (core operating income to DECLINE low-single-digits in 2026), and both Goldman and Jefferies say the premium multiple now hinges on second-half pipeline readouts. Our owner-earnings DCF (base ~$15.5B FCF, +2%/+5% growth, 7-8-9% discount, less $39.4B net debt, ~1.91B shares) centers near $128 vs the ~$150 price — about 15% below. Our call: HOLD, 3/5. Quality is not the question; the price is. We ALIGN with the Street's Hold (avg target ~$155, ~+4%) but are a shade more cautious. We'd own this fortress cheaper — under ~$120 — not here. Not financial advice. THE CALL: HOLD (3/5, A FORTRESS FRANCHISE THAT RETURNED TO GROWTH — BUT AT ~17x, WITH CORE PROFIT STILL FALLING AND NET DEBT DOUBLED, THE PRICE ALREADY PAYS FOR THE PIPELINE) — base-case value ~$128 vs ~$149.56 today. What to watch: clean wins in the second-half 2026 pipeline readouts (Goldman's bar: at least 2 of 3 major late-stage trials) or a return to core operating-income GROWTH in 2027 would justify the premium multiple and prompt an upgrade; the risks to respect are a guidance cut, a pipeline miss, or generic erosion (Entresto EU LOE in November) out-running the launch brands — watch the growth drivers and readouts each quarter Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  6. Jul 21

    Steel Dynamics Stock: Record Q2, Earnings +84% — But We Say HOLD (STLD Q2 2026)

    Steel Dynamics (STLD) Q2 2026 — Steel Dynamics (STLD), one of the largest U.S. electric-arc-furnace (EAF) steelmakers, reported a RECORD Q2 2026: net sales rose 33% to $6.1B, operating income jumped 83% to $700M, and diluted EPS surged 84% year-over-year to $3.69 — beating the company's own raised guidance of $3.51–$3.55 (even after a $16M non-cash impairment on relocating a planned aluminum site from Arizona to Columbus, Mississippi). Adjusted EBITDA was $921M on record steel shipments of 3.7M tons, as steel selling prices (ASP $1,298/ton, +$105 sequentially) outran ferrous scrap costs ($412/ton, +$16). The company generated $428M of operating cash flow, bought back $200M of stock (~1% of shares), and raised the dividend ~6% to $0.53/quarter. Yet the stock (~$230) sits ~20% BELOW its June 2026 high of $289, after nearly doubling off its 2025 low near $120. On honest mid-cycle math our blended fair value is ~$200 — below today's price. Our call: HOLD. Steel Dynamics is one of the largest and best-run steel producers in the United States — a low-cost electric-arc-furnace (EAF) 'mini-mill' operator that melts recycled scrap rather than smelting iron ore, giving it a structural cost and carbon advantage over legacy blast-furnace mills. It runs ~12M tons of annual steel capacity across four segments — steel operations (the core engine), metals recycling, steel fabrication, and a brand-new aluminum flat-rolled business — and earns a best-in-class ~13% three-year after-tax return on invested capital. Q2 2026 was a genuine blowout: net sales +33% to $6.1B, operating income +83% to $700M, and diluted EPS +84% to $3.69, beating its own raised $3.51–$3.55 guidance. The beat was operational, not accounting: metal spreads widened as steel ASP rose $105/ton to $1,298 while scrap rose just $16 to $412, on record shipments of 3.7M tons, and the steel-fabrication backlog is up 45% YoY into 2027. Segment operating income: Steel $721M, Fabrication $85M, Metals Recycling $48M — and Aluminum a $33M startup loss (narrowing 48% sequentially) as the 650,000-ton Columbus, MS mill ramps toward automotive qualification by end-2026. So why only a HOLD? Because steel is deeply CYCLICAL: today's fat spreads and record earnings sit near a strong point in the cycle, and the stock has already nearly doubled off its 2025 low. Valuing a cyclical on mid-cycle (not peak) owner earnings — normalized FCF of ~$1.75–2.05B/yr, discounted at 8/9/10% and net of ~$3.6B net debt — our two-scenario DCF spans ~$147–$210 (mid-cycle) and ~$191–$272 (up-cycle), blending to ~$200 at 9%, with a ~$150 downside if the cycle rolls over. That's BELOW the ~$230 price: no margin of safety. At ~21x trailing earnings and ~11–12x EV/EBITDA, STLD is fairly valued versus fellow EAF leader Nucor — a premium operator at a premium-operator multiple, not a bargain, with a slim ~0.9% dividend. Our verdict: HOLD, 3/5. A company to admire and a price to wait on — we're more cautious than Wall Street's Buy consensus and ~$272 average target. Not financial advice. THE CALL: HOLD (3/5, A GREAT COMPANY AT A CYCLICAL PRICE — RECORD QUARTER AND REAL ALUMINUM OPTIONALITY, BUT PEAK-ish EARNINGS AND NO MARGIN OF SAFETY AFTER A NEAR-DOUBLE OFF THE LOW) — base-case value ~$200 vs ~$230 today. What to watch: Watch metal spreads (steel ASP vs. ferrous scrap cost) above all else — the single biggest driver of quarterly profit — plus the aluminum ramp (shipments, yields, and the path to sustained profitability into 2027). We'd turn more constructive on a pullback toward ~$185 or below (closer to mid-cycle earnings support), or on clear evidence the 650k-ton aluminum mill is reaching durable profitability while steel spreads hold — which would add a fourth earnings engine and justify a higher value. The risk to respect is the opposite: spreads compressing (scrap rising faster than steel prices) or a construction/industrial slowdown, in which case earnings and the multiple compress together and the stock heads toward the ~$150 downside case. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  7. Jul 18

    Vista Energy Stock (VIST): EBITDA Nearly DOUBLED — So Why the ’Miss’? (Q2 2026)

    Vista Energy (VIST) Q2 2026 — Vista Energy (VIST) reported Q2 2026 (Jul 16): total revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY) at a 70% margin; production 156,061 boe/d (+32% YoY, ~87% oil), oil 135,427 bbl/d (+33%); realized oil $89.4/bbl (+44% YoY) at a $4.5/boe lifting cost. Reported EPS was $3.0 (+37% YoY, flattered by an acquisition gain), but ADJUSTED EPS of $2.38 MISSED the ~$3.15 consensus - the shortfall was below-the-line, as D,D&A jumped 53% to $271M and taxes doubled while Vista consolidated the Equinor (Bandurria Sur / Bajo del Toro) assets acquired in May. Capex $467M; free cash flow $491M ex-acquisition. Net debt $3.06B; net leverage 1.41x (1.25x pro forma), targeting ~1.0x by year-end. Guidance: ~158k boe/d for 2026 (Q4 ramping toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/- ~$200M per $10/bbl). The stock is ~$64, about 21% below its $81 high. Our EV/EBITDA work (4x 2026E EBITDA, with a deliberate Argentina discount) lands fair value ~$80. Wall Street: unanimous Buy (6/0/0), ~$85 average target. Our call: BUY, 3/5. Vista Energy is an Argentine oil producer and essentially a pure-play on Vaca Muerta - one of the best shale basins outside the U.S. In Q2 2026 the headline looked like a miss: adjusted EPS of $2.38 landed well short of the ~$3.15 consensus, and yet the operational quarter was a blowout - production up 32% to 156,061 boe/d, revenue up 89%, and adjusted EBITDA up 99% to $805M at a 70% margin. The 'miss' was below the line: reported EPS was actually $3.0 (up 37%, helped by an acquisition gain), but adjusted earnings were dragged by a 53% jump in depreciation (to $271M) and a doubling of taxes as Vista consolidated the Equinor assets (Bandurria Sur and Bajo del Toro) it acquired in May - the accounting cost of scaling up, not a crack in the business. Vista realized $89.40/bbl for its oil at a $4.50/boe lifting cost (one of the lowest anywhere), exports about two-thirds of its crude for hard currency, and generated $491M of free cash flow ex-acquisition. The deal did push net debt to $3.06B and leverage to 1.41x (1.25x pro forma), with management targeting ~1.0x by year-end. 2026 guidance: ~158k boe/d (Q4 toward ~170k) and ~$3.0B adjusted EBITDA at $85 Brent. On EV/EBITDA - the right lens for a commodity producer - Vista trades at barely ~3x this year's EBITDA; at 4x, with a deliberate Argentina discount, fair value is ~$80 vs ~$64 today. Wall Street is a unanimous Buy (6/0/0) with a ~$85 target. Our call: BUY, 3/5 - a cheap, fast-growing, low-cost oil producer, priced for an Argentina risk (FX, export duties, capital controls) that may be overdone but is genuinely un-hedgeable. Not financial advice. THE CALL: BUY (3/5, A CHEAP, FAST-GROWING, LOW-COST VACA MUERTA OIL PRODUCER, PRICED FOR ARGENTINA RISK THAT MAY BE OVERDONE) — base-case value ~$80 vs ~$64 today. KEY METRICS: - Revenue ~$1.21B (+89% YoY); adjusted EBITDA $805M (+99% YoY), 70% margin - Production 156,061 boe/d (+32% YoY, ~87% oil); oil 135,427 bbl/d (+33%) - Realized oil $89.4/bbl (+44% YoY); lifting cost $4.5/boe (world-class low) - Reported EPS $3.0 (+37%, acquisition gain); ADJUSTED EPS $2.38 vs ~$3.15 est (MISS) - D,D&A +53% to $271M, taxes doubled - Capex $467M; free cash flow $491M ex-acquisition; net debt $3.06B; leverage 1.41x (1.25x pro forma) -> ~1.0x target - Equinor deal (Bandurria Sur 25.1% + Bajo del Toro 35%) consolidated from May 1, 2026 - FY2026 guide: ~158k boe/d (Q4 ~170k) and ~$3.0B adjusted EBITDA at $85 Brent (+/-$200M per $10/bbl) - Our EV/EBITDA fair value ~$80 vs ~$64; Wall Street unanimous Buy (6/0/0), ~$85 avg target What to watch: Bullish confirmation: production ramping toward ~170k boe/d in Q4, net leverage falling back toward ~1.0x on free cash flow, and Brent holding near $85 - each would support a re-rating from ~3x toward peer multiples. The thesis breaks on an oil-price sell-off (every $10/bbl of Brent is ~$200M of second-half EBITDA) or an Argentine shock - peso devaluation, harsher export duties, or capital controls. Watch two dials above all: the Brent oil price and the net-leverage line. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  8. Jul 17

    ISRG Stock: Intuitive Surgical BEAT Q2 2026 — So Why Did It Crash 12%? (Cheap at Last, or Value Trap?)

    Intuitive Surgical (ISRG) Q2 2026 — Intuitive Surgical (ISRG) reported a clean Q2 2026 beat: revenue $2.89B (+19% YoY), non-GAAP EPS $2.80 (beat $2.48, +28%), GAAP EPS $2.29; worldwide procedures +16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 were da Vinci 5) vs 395 a year ago; installed base 11,710 (+12%). Instruments & accessories $1.73B (+18%, ~60% of revenue); non-GAAP gross margin 70.0%; operating margin >40%; $8.63B cash and zero debt; $0.38B buyback. Yet the stock FELL ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high — because FY26 da Vinci procedure-growth guidance of 13.5-15.5% marked a clear step down from the high-teens, alongside softer hospital surgery volumes and a da Vinci Class II component recall. Our owner-earnings DCF lands ~$343, essentially on top of the ~$352 price. Wall Street: Buy (39 of 56), avg target ~$525. Our call: HOLD, 3/5 — a premier compounder now at roughly fair value; not a bargain yet. Intuitive Surgical is the pioneer and monopoly of robotic-assisted surgery — the da Vinci system, the Ion lung-biopsy robot, and a razor-and-blade model where over 76% of revenue recurs. In Q2 2026 it delivered a clean beat: revenue $2.89B (+19%), non-GAAP EPS $2.80 (vs $2.48), worldwide procedures +16%, non-GAAP gross margin 70%, and 468 da Vinci placements (246 da Vinci 5), lifting the installed base 12% to 11,710. And yet the stock fell ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high. The reason isn't the quarter; it's the guide: FY26 da Vinci procedure growth of 13.5-15.5% (management points to the midpoint) is a step down from the high-teens pace of recent years, compounded by softer hospital volumes and a Class II recall. For a stock still near 33x forward earnings, decelerating procedure growth is the number that matters most. Our owner-earnings DCF (base ~$3.2B/yr, +$8.6B net cash) spans $246-$463 across 8-10% discount rates and 10-14% growth, with a probability-weighted value near $343 — roughly on top of today's ~$352. Wall Street rates it a Buy with a ~$525 target (nearly 50% upside), but even our bullish path only reaches the mid-$400s, and on the Street's own EPS estimates the math lands near our $343. Our call: HOLD, 3/5 — a wide-moat monopoly that has finally de-rated to fair value, but is not yet a bargain. Own the quality; look to add below $300; watch the quarterly procedure line above all else. Not financial advice. THE CALL: HOLD (3/5, A PREMIER SURGICAL-ROBOTICS MONOPOLY — NOW ROUGHLY FAIR, WAIT FOR A BETTER PRICE) — base-case value ~$343 vs ~$352 today. What to watch: da Vinci procedure growth stabilizing and re-accelerating back toward the high-teens (da Vinci 5 lifting procedures per system), which would justify the premium multiple — or, conversely, a pullback below ~$300 that opens a genuine margin of safety and turns us to a buy; the thesis breaks if procedure growth slides below 12% or tariff/competition pressures compress margins Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

See All (1K)

About

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close: what they do, how the numbers look, what Wall Street thinks, the bull case, the bear case. 🛠️ Check out our free beginner-friendly screening tools for stocks, ETFs, options, crypto, bonds, REITs & more at https://chargedalpha.com — no signup, no paywall. 📊 What you get in every episode: Company overview & competitive moat Full financial breakdown — valuation, revenue, margins, cash flow Analyst consensus & price targets Bull case vs. bear case Peer comparison, options flow & insider activity Key metrics to watch ⚠️ Not financial advice. For educational purposes only. Episodes are researched, written, and produced using AI-assisted tools. All data aggregated from publicly available sources. #stocks #investing #S&P500 #stockanalysis #chargedalpha #financialdata #earningsreport #earnings

Information